dipalmitoylphosphatidylcholine
Small moleculeexperimental
Dipalmitoylphosphatidylcholine (DPPC) is a phospholipid (and a lecithin) consisting of two C16 palmitic acid groups attached to a phosphatidylcholine head-group. — Wikipedia
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 27, 2018 (NCT03748758)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaDipalmitoylphosphatidylcholine ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03828149 | Phase 1 | Feb 8, 2019 | Novus Pharma |
| NCT03766373 | Phase 1 | Jan 7, 2019 | Novus Pharma |
| NCT03748758 | Phase 1 | Nov 27, 2018 | Novus Pharma |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Novus Pharma | For profit | 3 | 3 | 1 | 2018 |
1 organizations
Page 1 / 1